Oropouche virus goes global: Study exposes new risks from viral reassortment

A new study uncovers how Oropouche virus is breaking out of the Amazon, spreading across Brazil and beyond. Scientists warn that environmental changes, human mobility, and viral evolution are driving its rapid expansion—raising urgent concerns for global public health.

Study: Travel-associated international spread of Oropouche virus beyond the Amazon. Image Credit: CI Photos / ShutterstockStudy: Travel-associated international spread of Oropouche virus beyond the Amazon. Image Credit: CI Photos / Shutterstock

Oropouche virus (OROV), historically confined to the Brazilian Amazon Basin, has caused multiple outbreaks across many Brazilian states since 2022. Many OROV cases have also been detected beyond Brazil in recent times.

Researchers have conducted whole-genome sequencing of viral isolates collected from outbreak regions to understand the dynamics of viral transmission to non-endemic regions. The study is published in the Journal of Travel Medicine.

Background

Oropouche virus (OROV) is an arthropod-borne, single-stranded, negative-sense RNA virus segmented into three parts: small, medium, and large. These three segments encode essential components required for viral growth, transmission, and infectivity.

After its first detection in Trinidad and Tobago in 1955, the virus has caused several outbreaks among animals (non-human primates, sloths, and birds) in the Amazon Basin. In humans, the virus is primarily transmitted by midges (Culicoides paraenesis) and causes mild to moderate infections that resolve within a week.

Up until August 2024, approximately 30 outbreaks have been reported in Latin America. However, recent epidemiological data demonstrates a sharp increase in OROV cases across multiple non-endemic Brazilian states, with travel-related cases reported in Italy, Spain, and Germany originating from travelers who visited Cuba.

The first three fatal cases of OROV infection have also been reported in Brazil in 2024. All these reports highlight the spread of the virus outside the Amazon and raise concerns among public health authorities.

Study Design

Researchers conducted whole-genome sequencing of OROV-infected patient-derived samples collected from five Brazilian states between February and May 2024. They selected the samples for genomic analysis based on the available clinical and epidemiological metadata.

They generated 133 whole-genome sequences covering the virus’s three genomic segments: the small, medium, and large segments. These sequences included the first genomes from regions outside the Amazon and from the first recorded fatal cases.

Study Findings

The study reported a sharp rise in OROV infections in humans in the western Amazon region between late 2022 and early 2024. This induction coincided with a surge in OROV testing frequency (from 238 tests in 2020 to 54,428 in early 2024) across the country, indicating intensified surveillance efforts.

The phylogenetic analysis revealed that the new viral sequences generated in the study share a common ancestor with sequences obtained from the Amazon Basin sampled since 2022, suggesting a possible Amazonian origin of the recent viral lineage.

Because of its segmented pattern, the OROV genome is likely to undergo reassortment and recombination events. The study identified 21 reassortment events (including 17 S-M, 7 S-L, and 11 M-L reassortments). However, whether these genomic changes have facilitated viral adaptation to local ecological conditions or contributed to its infectivity and pathogenicity remained unclear.

By conducting a phylogeographic reconstruction of the 2022–2024 Brazilian dataset together with recently isolated international genome sequences from Peru and Italy, the study found a rapid north-to-south viral transmission within Brazil, followed by cross-border transmission into Peru.

The study also found that OROV cases reported in Italy are associated with travelers who returned from Cuba. However, Cuban cases are inferred solely from travel history, as genomic data from Cuba itself are unavailable, limiting definitive conclusions about transmission routes. These observations highlight the role of human mobility in viral spreading.

Study Significance

The study demonstrates how OROV evolution through genomic reassortment has facilitated its rapid transmission within and beyond Brazil. The findings indicate that the 2022–2024 lineage of OROV might have emerged in central Amazonas between 2010 and 2014, with evidence of long-term cryptic circulation in the Amazon during the late 2010s due to limited surveillance.

The study’s north-to-south viral movement coincides with the Amazon Basin’s rainy season. Existing eco-epidemiological studies suggest that OROV preferentially circulates in regions with high population density, favorable climatic conditions, and reduced evergreen broadleaf forest cover.

Furthermore, deforestation, urbanization, and agricultural practices (e.g., banana and cocoa farming) facilitate midge breeding, increasing the risk of viral transmission and shaping the virus’s geographical range.
The detection of the first three fatal OROV cases in young adults without comorbidities —including mutations in the M (I13V, M642I) and L (T857A) segments— highlights the need for further investigations, with a particular focus on vertical transmission and pregnancy outcomes.

The Brazilian Ministry of Health has recently reported the first fetal death due to OROV with mother-to-child transmission in Pernambuco. However, asymptomatic or mild cases may be underrepresented in genomic datasets, biasing surveillance efforts. This highlights the need to identify viral factors associated with severe outcomes and develop effective interventions.

The study identified travel-related OROV cases, which indicate that human mobility plays a vital role in viral spreading beyond Brazil. Key limitations include the lack of genomic data from Colombia, Cuba, and other affected countries, preventing a complete understanding of transmission networks.

Overall, the study highlights the urgency for continuous genomic surveillance to understand the evolutionary and epidemiological dynamics of OROV. This is particularly important for preventing future outbreaks and ensuring timely public health responses.

Journal reference:
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha Dutta. (2025, March 04). Oropouche virus goes global: Study exposes new risks from viral reassortment. News-Medical. Retrieved on March 04, 2025 from https://www.news-medical.net/news/20250304/Oropouche-virus-goes-global-Study-exposes-new-risks-from-viral-reassortment.aspx.

  • MLA

    Dutta, Sanchari Sinha Dutta. "Oropouche virus goes global: Study exposes new risks from viral reassortment". News-Medical. 04 March 2025. <https://www.news-medical.net/news/20250304/Oropouche-virus-goes-global-Study-exposes-new-risks-from-viral-reassortment.aspx>.

  • Chicago

    Dutta, Sanchari Sinha Dutta. "Oropouche virus goes global: Study exposes new risks from viral reassortment". News-Medical. https://www.news-medical.net/news/20250304/Oropouche-virus-goes-global-Study-exposes-new-risks-from-viral-reassortment.aspx. (accessed March 04, 2025).

  • Harvard

    Dutta, Sanchari Sinha Dutta. 2025. Oropouche virus goes global: Study exposes new risks from viral reassortment. News-Medical, viewed 04 March 2025, https://www.news-medical.net/news/20250304/Oropouche-virus-goes-global-Study-exposes-new-risks-from-viral-reassortment.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.